Anticonvulsant Potential of Bacopa monnieri Saponins in a Chemically Induced Seizure Model

Abstract

Background: Standardized bacoside fractions can be used as leads to adjunctive antiseizure studies. Objective: In order to compare bacoside-enriched Bacopa monnieri saponin fraction with vehicle control and sodium valproate reference using a controlled animal experiment. Methods: The protocol was in the form of a draft consisting of 48 experimental units or participants, who were adult Swiss albino mice, who were put to the test using pentylenetetrazole. The intervention was done or tested over 14 days. The main outcome was latency to generalized seizure, and secondary measurements of seizure severity score, mortality, GABA concentration in the brain, oxidative stress in the hippocampal. The procedures used were standardized laboratory, clinical, or food-analysis tests and compared between conditions using two-sided tests α=0.05. Results: High-dose Bacopa saponins prolonged latency to generalized seizure from 92 ± 18 seconds to 238 ± 31 seconds and reduced the mean seizure score from 4.6 ± 0.5 to 2.5 ± 0.6 (p<0.001). There were no deaths in the high dose arm; there was an increase in brain GABA to 3.1 ± 0.4 µmol/g and a reduction of malondialdehyde by 47.3% compared to the vehicle-treated controls of the seizure activity.
The direction and magnitude of the dummy results were internally consistent between the primary and secondary endpoints and tolerability or assay-quality measures were acceptable. Conclusion: The example data indicate that the bacoside-enriched Bacopa monnieri saponin fraction may result in a significant reduction in latency to generalized seizure by improving inhibitory neurotransmission and preventing oxidative damage of seizure. The findings are merely an example of a full manuscript development and they need to be substituted with ethically obtained, independent-verified observations prior to scientific submission. Keywords: Bacopa monnieri; bacosides; seizure; GABA; anticonvulsant